Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Quality Index
Shenzhen Salubris Pharmaceuticals Co Ltd cash flow quality index. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow Quality Index of 1.86x as of September 2025. Operating cash flow of CN¥400.70 Million exceeds net income of CN¥215.63 Million, indicating high earnings quality where cash backs reported profits. Explore 002294 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Cash flow quality index of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. Historical Cash Flow Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Shenzhen Salubris Pharmaceuticals Co Ltd (002294) balance sheet quality index to measure how much of total assets are equity-financed.
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Quality Index by Year (2006–2024)
Shenzhen Salubris Pharmaceuticals Co Ltd cash flow quality index by year from 2006 to 2024. Year-by-year earnings quality comparison for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Shenzhen Salubris Pharmaceuticals Co Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.96x | CN¥1.19 Billion | CN¥605.16 Million | ▲ +30.7% |
| 2023 | 1.50x | CN¥869.79 Million | CN¥580.07 Million | ▼ -2.0% |
| 2022 | 1.53x | CN¥970.80 Million | CN¥634.22 Million | ▼ -31.8% |
| 2021 | 2.24x | CN¥1.18 Billion | CN¥528.32 Million | ▼ -91.8% |
| 2020 | 27.41x | CN¥1.37 Billion | CN¥50.13 Million | ▲ +1140.6% |
| 2019 | 2.21x | CN¥1.51 Billion | CN¥681.84 Million | ▲ +139.7% |
| 2018 | 0.92x | CN¥1.34 Billion | CN¥1.45 Billion | ▼ -9.1% |
| 2017 | 1.01x | CN¥1.46 Billion | CN¥1.44 Billion | ▼ -1.7% |
| 2016 | 1.03x | CN¥1.43 Billion | CN¥1.39 Billion | ▲ +24.1% |
| 2015 | 0.83x | CN¥1.06 Billion | CN¥1.27 Billion | ▼ -11.7% |
| 2014 | 0.94x | CN¥982.25 Million | CN¥1.04 Billion | ▲ +17.3% |
| 2013 | 0.80x | CN¥668.52 Million | CN¥833.26 Million | ▼ -2.2% |
| 2012 | 0.82x | CN¥521.21 Million | CN¥635.55 Million | ▲ +22.1% |
| 2011 | 0.67x | CN¥272.32 Million | CN¥405.45 Million | ▲ +27.9% |
| 2010 | 0.53x | CN¥186.65 Million | CN¥355.51 Million | ▼ -15.7% |
| 2009 | 0.62x | CN¥134.28 Million | CN¥215.68 Million | ▼ -6.5% |
| 2008 | 0.67x | CN¥77.89 Million | CN¥116.94 Million | ▼ -7.7% |
| 2007 | 0.72x | CN¥52.75 Million | CN¥73.14 Million | ▲ +105.7% |
| 2006 | 0.35x | CN¥12.00 Million | CN¥34.24 Million | — |